Natalie E. Simpson

1.0k total citations
19 papers, 649 citations indexed

About

Natalie E. Simpson is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Natalie E. Simpson has authored 19 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Natalie E. Simpson's work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (4 papers) and RNA modifications and cancer (3 papers). Natalie E. Simpson is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (4 papers) and RNA modifications and cancer (3 papers). Natalie E. Simpson collaborates with scholars based in United States, United Kingdom and Switzerland. Natalie E. Simpson's co-authors include Igor P. Pogribny, Frederick A. Beland, Volodymyr Tryndyak, Ronald A. DePinho, Gregory David, Kathryn B. Grandinetti, Gerald C. Chu, John K. Leighton, Haleh Saber and Tiffany K. Ricks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Natalie E. Simpson

18 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie E. Simpson United States	14	376	169	123	106	71	19	649
Kathleen M. Gillooly United States	14	263 0.7×	166 1.0×	146 1.2×	263 2.5×	38 0.5×	17	778
Michael P. Sheets United States	13	584 1.6×	152 0.9×	74 0.6×	124 1.2×	73 1.0×	22	967
Emmanuel Petricoin United States	11	597 1.6×	146 0.9×	146 1.2×	57 0.5×	71 1.0×	19	871
Nanni Huser United States	8	737 2.0×	238 1.4×	84 0.7×	100 0.9×	27 0.4×	15	999
Rosemary C. McFall United States	15	374 1.0×	170 1.0×	140 1.1×	46 0.4×	50 0.7×	23	880
Lanfang Bai United States	7	526 1.4×	138 0.8×	82 0.7×	145 1.4×	135 1.9×	12	818
Jennifer M. Shipman United States	11	378 1.0×	128 0.8×	123 1.0×	52 0.5×	32 0.5×	13	539
Karen M. Holdaway New Zealand	15	464 1.2×	279 1.7×	132 1.1×	108 1.0×	27 0.4×	19	776
Chris J. Novotny United States	9	642 1.7×	179 1.1×	82 0.7×	61 0.6×	24 0.3×	10	829
Ruth Ruddle United Kingdom	12	409 1.1×	137 0.8×	98 0.8×	36 0.3×	57 0.8×	23	652

Countries citing papers authored by Natalie E. Simpson

Since Specialization

Citations

This map shows the geographic impact of Natalie E. Simpson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie E. Simpson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie E. Simpson more than expected).

Fields of papers citing papers by Natalie E. Simpson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie E. Simpson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie E. Simpson. The network helps show where Natalie E. Simpson may publish in the future.

Co-authorship network of co-authors of Natalie E. Simpson

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie E. Simpson. A scholar is included among the top collaborators of Natalie E. Simpson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie E. Simpson. Natalie E. Simpson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Simpson, Natalie E., et al.. (2025). High-Temperature Oxidation and Thermal Expansion Behavior of NbTi–X (X = 5Co, 10Cr, 10Ni, 10CoCrNi) Refractory Medium Entropy Alloys. Metallurgical and Materials Transactions A. 56(10). 4436–4453.

Simpson, Natalie E., Todd Bourcier, & Nakissa Sadrieh. (2025). A Food and Drug Administration/Center for Drug Evaluation and Research nonclinical perspective on the use of human-induced pluripotent stem cell-derived cardiomyocyte data for cardiovascular safety assessment and regulatory decisions. Toxicological Sciences. 206(2). 219–227. 1 indexed citations

Baines, Andrea, Bindu Kanapuru, Guoxiang Shen, et al.. (2022). FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma. Clinical Cancer Research. 28(21). 4629–4633. 34 indexed citations

Jen, Emily Y., Xin Gao, Liang Li, et al.. (2019). FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical Cancer Research. 26(3). 532–536. 65 indexed citations

Saber, Haleh, Natalie E. Simpson, Tiffany K. Ricks, & John K. Leighton. (2019). An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates. Regulatory Toxicology and Pharmacology. 107. 104429–104429. 61 indexed citations

Papoian, Thomas, Gowraganahalli Jagadeesh, Muriel Saulnier, et al.. (2017). Regulatory Forum Review*: Utility ofin VitroSecondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations. Toxicologic Pathology. 45(3). 381–388. 23 indexed citations

Papoian, Thomas, Haw-Jyh Chiu, Ikram Elayan, et al.. (2015). Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective. Nature Reviews Drug Discovery. 14(4). 294–294. 47 indexed citations

Simpson, Natalie E., Volodymyr Tryndyak, Marta Pogribna, Frederick A. Beland, & Igor P. Pogribny. (2012). Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype. Epigenetics. 7(12). 1413–1420. 60 indexed citations

Syed, Binafsha Manzoor, Simon J. Johnston, Andrew R. Green, et al.. (2011). Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic. Annals of Oncology. 23(6). 1465–1471. 24 indexed citations

10.

Simpson, Natalie E., Volodymyr Tryndyak, Frederick A. Beland, & Igor P. Pogribny. (2011). An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression. Breast Cancer Research and Treatment. 133(3). 959–968. 61 indexed citations

11.

Koturbash, Igor, Natalie E. Simpson, Frederick A. Beland, & Igor P. Pogribny. (2011). Alterations in Histone H4 Lysine 20 Methylation: Implications for Cancer Detection and Prevention. Antioxidants and Redox Signaling. 17(2). 365–374. 16 indexed citations

12.

Simpson, Natalie E., Binafsha Manzoor Syed, D.A.L. Morgan, Ian O. Ellis, & Ka Man Cheung. (2011). Pattern of estrogen receptor (ER)/progesterone receptor (PR)/HER2 expression in older women with primary breast cancer based on core needle biopsies and correlation with short-term clinical outcome.. Journal of Clinical Oncology. 29(15_suppl). e21104–e21104. 2 indexed citations

13.

Simpson, Natalie E., Volodymyr Tryndyak, Frederick A. Beland, & Igor P. Pogribny. (2011). Abstract 3021: An in vitro investigation of metabolically sensitive epigenetic biomarkers in breast cancer progression. Cancer Research. 71(8_Supplement). 3021–3021. 1 indexed citations

14.

Simpson, Natalie E., et al.. (2011). Research Resource: Enhanced Genome-Wide Occupancy of Estrogen Receptor α by the Cochaperone p23 in Breast Cancer Cells. Molecular Endocrinology. 26(1). 194–202. 16 indexed citations

15.

Simpson, Natalie E., W. Marcus Lambert, Shah Giashuddin, et al.. (2010). High Levels of Hsp90 Cochaperone p23 Promote Tumor Progression and Poor Prognosis in Breast Cancer by Increasing Lymph Node Metastases and Drug Resistance. Cancer Research. 70(21). 8446–8456. 48 indexed citations

16.

Chong, Mark M. W., Natalie E. Simpson, Maria Ciofani, et al.. (2010). Epigenetic propagation of CD4 expression is established by theCd4proximal enhancer in helper T cells. Genes & Development. 24(7). 659–669. 53 indexed citations

17.

David, Gregory, et al.. (2008). Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proceedings of the National Academy of Sciences. 105(11). 4168–4172. 93 indexed citations

18.

David, Gregory, Natalie E. Simpson, Lili Miao, et al.. (2006). Haploinsufficiency of the mSds3 chromatin regulator promotes chromosomal instability and cancer only upon complete neutralization of p53. Oncogene. 25(56). 7354–7360. 13 indexed citations

19.

Evans, D. Gareth, David Grimwade, H. G. Prentice, & Natalie E. Simpson. (1997). Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all‐trans retinoic acid. British Journal of Haematology. 98(2). 437–439. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact